UCSF 40th Annual Advances In Heart Disease 2023

Overview

UCSF 40th Annual Advances In Heart Disease 2023 presents the latest evidence-based updates across cardiology subspecialties, including heart failure, arrhythmias, cardiac surgery, gene therapy, aortic diseases, prevention, and artificial intelligence. This on-demand cardiology education course features 26 MP4 video files and 25 PDF documents, with a total size of 15.57 GB, providing comprehensive access to recent advances impacting clinical practice.

On-demand cardiology education — accessible anytime, anywhere.

Format: 26 MP4 + 25 PDF Files
Total size: 15.57 GB

Agenda

This course delivers expert discussions and lectures covering a wide range of cardiovascular topics, structured over three days of presentations originally held in December 2023. The agenda includes sessions on artificial intelligence, pulmonary hypertension, heart failure management, electrophysiology controversies, and cardiovascular risk management.

• Artificial Intelligence and Cardiology Debate: Sonographer vs. AI — David Ouyang, MD
• Myocarditis: Where Are We in 2023? — Bettina Heidecker, MD
• Genetics, Artificial Intelligence and the Heart — James Pirruccello, MD
• Pulmonary Hypertension – What is New in 2023 — Marc Simon, MD
• Peripheral Vascular Disease Updates in 2023 — Eric Secemsky, MD
• Elliot Rapaport Keynote Lecture: Earning Trust: The Heart of the Matter — Julie Gerberding, MD
• Interventional Approaches to Heart Failure — Lucas Zier, MD, MS
• Improving Outcomes in Acute Pulmonary Embolism — Antonio Gomez, MD
• Neuroprotection Strategies After Cardiac Arrest — Claude Hemphill, MD
• Modern Role of the Ross Procedure in the Treatment of Aortic Valve Disease — Marko Boskovski, MD, MHS, MPH
• The Current State and Future Direction of Critical Care Cardiology — Chris Barnett, MD and Connor O’Brien, MD
• Debate: Older Patients with High CHADS-VASC and Bleeding Risk Should Have Left Atrial Appendage Closed — Tommy Dewland, MD (pro), Adam Lee, MD (con)
• Pacing for Heart Failure with Preserved Ejection Fraction — Ram Venkateswaran, MD
• Debate: Treatment for Symptomatic Atrial Fibrillation First-line Ablation vs. Pharmacologic Therapy — Ed Gerstenfeld, MD and Joshua Moss, MD
• New Technologies in Pacing for Central Sleep Apnea and Heart Failure — Byron Lee, MD
• The Effect of Alcohol, Caffeine and Tobacco on Atrial Fibrillation – Are Any Vices OK? — Gregory Marcus, MD, MAS
• Polypharmacy and Medication Costs for Guideline Directed Medical Therapy for Patients with Heart Failure with Reduced Ejection Fraction — Rose Pavlakos, PharmD
• Remote Monitoring of Patients with Heart Failure — Liviu Klein, MD, MS
• Right Ventricular Heart Failure — Brian Houston, MD
• Review of Guideline for and Management of Heart Failure — Jonathan Davis, MD, MPHS
• Approach to Multivessel Coronary Artery Disease in Patients with Reduced Ejection Fraction — Amy Fiedler, MD and Krishan Soni, MD, MBA
• Clonal Hematopoiesis of Indeterminate Potential (CHIP): A Novel Cardiovascular Risk Factor — Peter Libby, MD
• Lipid Management Beyond Statins: What, Why, and Who? — Christie Ballantyne, MD
• Lp(a): Why is It Important? — Michelle O’Donoghue, MD, MPH
• Weight Loss and Cardiovascular Risk: Current Concepts — Sarah Kim, MD
• Making Sense of Popular Diets: Alignment with AHA 2021 Dietary Guidance — Christopher Gardner, PhD

Objectives

After completing UCSF 40th Annual Advances In Heart Disease 2023, attendees will be able to:

• Provide optimal management for coronary heart disease, hypertension, lipid disorders, diabetes, systolic and diastolic heart failure, atrial fibrillation and flutter, STEMI and non-STEMI, and thromboembolic disease
• Refine approaches to atrial fibrillation, atrial flutter, and ventricular tachycardia ablation
• Apply best practices in percutaneous coronary interventions
• Enhance use of anti-platelet and anticoagulation therapies for cardiovascular conditions
• Identify cardiovascular risk stratification methods
• Optimize management strategies for peripheral artery disease
• Recognize and address the differing pathophysiology and treatment considerations among racial and ethnic groups
• Improve management of COVID-19-related cardiovascular complications

Speakers

This program features a distinguished faculty of academic leaders and clinicians from the University of California, San Francisco, alongside visiting experts specializing in diverse areas of cardiology. Presenters provide authoritative insights relevant to complex cardiovascular care and research developments.

Target Audience

This course is intended for cardiologists, internal medicine physicians, cardiovascular surgeons, advanced practice providers, and other healthcare professionals involved in the management of patients with cardiovascular diseases seeking to update their clinical knowledge and skills.

Why This Topic Matters

UCSF 40th Annual Advances In Heart Disease 2023 addresses contemporary challenges in cardiology by presenting recent evidence-based findings that inform clinical decision-making and patient care. This focused cardiology update supports healthcare professionals in strengthening their expertise across a range of cardiovascular conditions and innovations.

Available on MedHub Central, this course enables clinicians to engage with evolving topics including artificial intelligence applications, electrophysiology controversies, and novel therapies. It facilitates continued professional development within cardiology by providing accessible, in-depth content grounded in current research and practice.